Neo Ivy Capital Management - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 5 filers reported holding SEATTLE GENETICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2021$380,000
+30.1%
2,239
+49.9%
0.44%
+47.8%
Q3 2020$292,000
-23.2%
1,494
-33.3%
0.30%
+104.9%
Q2 2020$380,000
+187.9%
2,239
+96.4%
0.14%
-33.0%
Q1 2020$132,000
-11.4%
1,140
-44.3%
0.22%
+121.6%
Q3 2019$149,0002,0480.10%
Other shareholders
SEATTLE GENETICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Baker Brothers Advisors 50,060,240$5,775,950,00035.57%
Lagoda Investment Management, L.P. 72,969$8,419,0009.97%
Avidity Partners Management LP 580,000$66,920,0009.25%
Arabesque Asset Management Ltd 14,807$1,708,0003.53%
Boxer Capital, LLC 400,000$46,152,0003.15%
Woodline Partners LP 364,333$42,037,0003.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,900$6,557,0002.99%
SECTORAL ASSET MANAGEMENT INC 107,000$12,346,0002.37%
Capital International, Inc./CA/ 1,197,659$138,186,0002.33%
Bain Capital Public Equity Management II, LLC 169,641$19,573,0002.29%
View complete list of SEATTLE GENETICS INC shareholders